Literature DB >> 4066573

Antagonism by theophylline of respiratory inhibition induced by adenosine.

F L Eldridge, D E Millhorn, J P Kiley.   

Abstract

The effects on respiration of an analogue of adenosine, L-2-N6-(phenylisopropyl)adenosine (PIA), and of the methylxanthine, theophylline, were determined in 19 vagotomized glomectomized cats whose end-tidal PCO2 was kept constant by means of a servo-controlled ventilator. Integrated phrenic nerve activity was used to represent respiratory output. Our results show that PIA, whether given systemically or into the third cerebral ventricle, depressed respiration. Systemically administered theophylline stimulated respiration. Theophylline given intravenously, or into the third ventricle not only reversed the depressive effects of previously administered PIA but caused further increases of respiration above the control level. Prior systemic administration of theophylline blocked both respiratory and hypotensive effects of subsequently administered PIA. Effects of either agent on medullary extracellular fluid pH did not explain the results. We conclude that the adenosine analogue PIA, acts to inhibit neurons in the brain that are involved in the control of respiration and that its effects are blocked by theophylline. We suggest that adenosine acts as a tonic modulator of respiration and that theophylline stimulates breathing by competitive antagonism of adenosine at neuronal receptor sites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066573     DOI: 10.1152/jappl.1985.59.5.1428

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  18 in total

1.  Inhibition of the hypercapnic ventilatory response by adenosine in the retrotrapezoid nucleus in awake rats.

Authors:  Bárbara Falquetto; Luiz M Oliveira; Ana C Takakura; Daniel K Mulkey; Thiago S Moreira
Journal:  Neuropharmacology       Date:  2018-05-23       Impact factor: 5.250

2.  Changes in the biochemical profiles of mid-cervically located adenosine A1 receptors after repeated theophylline administration in adult rats.

Authors:  Rubabe S Saharan; Kwaku D Nantwi
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

3.  Respiratory arrest during dipyridamole stress testing.

Authors:  G S Hillis; A al-Mohammad; K P Jennings
Journal:  Postgrad Med J       Date:  1997-05       Impact factor: 2.401

4.  Adenosine in heart and lung disease. Proceedings of the first Cardiothoracic Institute Workshop. 30 March 1988, London. Abstracts.

Authors: 
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

5.  Diaphragmatic recovery in rats with cervical spinal cord injury induced by a theophylline nanoconjugate: Challenges for clinical use.

Authors:  Fangchao Liu; Yanhua Zhang; Janelle Schafer; Guangzhao Mao; Harry G Goshgarian
Journal:  J Spinal Cord Med       Date:  2019-03-07       Impact factor: 1.985

6.  Involvement of peripheral adenosine A2 receptors in adenosine A1 receptor-mediated recovery of respiratory motor function after upper cervical spinal cord hemisection.

Authors:  Elysia James; Kwaku D Nantwi
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

7.  The role of adenosine in the respiratory and cardiovascular response to systemic hypoxia in the rat.

Authors:  M Neylon; J M Marshall
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

Review 8.  Central sleep apnea: implications for congestive heart failure.

Authors:  Arturo Garcia-Touchard; Virend K Somers; Lyle J Olson; Sean M Caples
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Central adenosine A1 receptors inhibit cough via suppression of excitatory glutamatergic and tachykininergic neurotransmission.

Authors:  Ahmed Z El-Hashim; Seena Mathews; Fajer Al-Shamlan
Journal:  Br J Pharmacol       Date:  2018-06-19       Impact factor: 8.739

Review 10.  Recovery of respiratory activity after C2 hemisection (C2HS): involvement of adenosinergic mechanisms.

Authors:  Kwaku D Nantwi
Journal:  Respir Physiol Neurobiol       Date:  2009-08-03       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.